Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
1 Despite remarkable advances in targeted therapies, immunotherapies, and combination regimens, a significant proportion of patients experience either intrinsic resistance, where tumors fail to respond from the outset, or acquired resistance, which emerges after an initial therapeutic response
W.ChoiS
Lilly states that it is not available for public use outside its clinical trials in its July 2026 retatrutide update
JCI Insight 8 , e167274 (2023)
Keep the cartridges refrigerated at a temperature between 2C and 8C to prevent degradation
US$ 20.17
US$ 27.49
US$ 29.79
US$ 27.73
